文献速递肝病

线粒体甘油-3-磷酸脱氢酶缺陷促进肝脏脂肪变性

Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Contributes to Hepatic Steatosis.
PubMed 文献 · Hepatology · 2019-03-15

研究发现非酒精性脂肪性肝病(NAFLD)患者及NAFLD小鼠(ob/ob、高脂饮食、db/db)肝脏中mGPDH表达与活性降低;小鼠肝脏特异性敲除mGPDH或培养肝细胞中敲低mGPDH可通过增强脂肪生成加重饮食诱导的甘油三酯蓄积和脂肪变性。机制上mGPDH缺陷通过抑制Cyp-D泛素化诱导内质网应激,进而导致肝脏脂肪变性;肝脏特异性过表达mGPDH可减轻ob/ob和高脂饮食小鼠的肝脏脂肪变性。

要点

  • NAFLD患者及多种NAFLD小鼠模型肝脏中mGPDH表达和活性均降低。
  • mGPDH缺陷通过增强脂肪生成加重饮食诱导的肝脏甘油三酯蓄积和脂肪变性。
  • mGPDH缺陷通过抑制Cyp-D泛素化诱导内质网应激,从而促进肝脏脂肪变性。

核心结论

  • mGPDH是肝脏脂质代谢的关键调控因子,其缺陷通过抑制Cyp-D泛素化诱导内质网应激并导致肝脏脂肪变性,mGPDH可能是治疗NAFLD的潜在靶点。

研究设计与样本

  • 研究检测了NAFLD患者及ob/ob、高脂饮食和db/db小鼠肝脏中mGPDH的表达与活性,并在小鼠肝脏特异性敲除mGPDH、培养肝细胞中敲低mGPDH以及小鼠肝脏特异性过表达mGPDH的模型中观察其对肝脏脂肪变性的影响。

主要发现

  • NAFLD患者和ob/ob、高脂饮食及db/db小鼠脂肪肝中mGPDH表达与活性低于对照。
  • 小鼠肝脏特异性敲除mGPDH或培养肝细胞中敲低mGPDH可通过增强脂肪生成加重饮食诱导的甘油三酯蓄积和脂肪变性。
  • RNA测序显示mGPDH调控内质网相关蛋白和过程;mGPDH缺失加重衣霉素诱导的肝脏脂肪变性,而牛磺熊去氧胆酸可逆转mGPDH缺失在高脂饮食下诱导的脂肪变性。
  • mGPDH缺失诱导的内质网应激可被细胞内Ca2+螯合剂BAPTA-AM、线粒体通透性转换孔(mPTP)抑制剂环孢素A或Cyp-D敲低所消除,并观察到mGPDH促进Cyp-D泛素化。
  • 肝脏特异性过表达mGPDH可减轻ob/ob和高脂饮食小鼠的肝脏脂肪变性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mitochondrial glycerol 3-phosphate dehydrogenase (mGPDH) is an integral component of the respiratory chain, and recent studies have suggested that it plays an important role in hepatic glucose homeostasis. However, its function in hepatic lipid metabolism is unclear. Here, we identified a role for mGPDH in nonalcoholic fatty liver disease (NAFLD). Specifically, mGPDH expression and activity were lower in fatty livers from patients and mice with NAFLD (ob/ob, high-fat diet [HFD] and db/db). Liver-specific depletion of mGPDH in mice or mGPDH knockdown in cultured hepatocytes exacerbated diet-induced triglyceride accumulation and steatosis through enhanced lipogenesis. RNA-sequencing revealed that mGPDH regulated endoplasmic reticulum (ER)-related proteins and processes. mGPDH deletion exacerbated tunicamycin (ER stress inducer)-induced hepatic steatosis, whereas tauroursodeoxycholic acid (ER stress inhibitor) rescued mGPDH depletion-induced steatosis on an HFD. Moreover, ER stress induced by mGPDH depletion could be abrogated by the intracellular Ca2+ chelator 1,2-bis (2-aminophenoxy) ethane N,N,N´,N´-tetraacetic acid acetoxymethyl ester, mitochondrial permeability transition pore (mPTP) inhibitor cyclosporine A, or cyclophilin-D (Cyp-D) knockdown. mGPDH promoting Cyp-D ubiquitination was also observed. Finally, liver-specific mGPDH overexpression attenuated hepatic steatosis in ob/ob and HFD mice. Conclusion: mGPDH is a pivotal regulator of hepatic lipid metabolism. Its deficiency induces ER stress by suppressing Cyp-D ubiquitination, a key regulator of the mitochondrial Ca2+ conductance channel mPTP, and results in hepatic steatosis. mGPDH may be a potential therapeutic target for the treatment of NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zheng Y, Qu H, Xiong X, et al. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Contributes to Hepatic Steatosis. Hepatology. 2019. PMID: 30653687. doi:10.1002/hep.30507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。